The Technical Analyst
Select Language :
Eucrates Biomedical [EUCRU]

Exchange: NASDAQ Capital Market Sector: Financial Services Industry: Shell Companies

Eucrates Biomedical Price, Forecast, Insider, Ratings, Fundamentals & Signals

Eucrates Biomedical is listed at the NASDAQ Exchange

-0.69% $10.02

/ 26 apr 2023 @ 15:59


Eucrates Biomedical: Main Fundamentals PE comparison

FUNDAMENTALS
MarketCap: 47.26 mill
EPS: 0.234
P/E: 42.82
Earnings Date: Dec 30, 2022
SharesOutstanding: 4.72 mill
Avg Daily Volume: 0.0006 mill
RATING 2023-05-05
A+
Strong Buy
RATINGS
Rating CashFlow: Neutral
Return On Equity: Strong Buy
Return On Asset: Strong Buy
DE: Sell
P/E: Strong Buy
Price To Book: Strong Buy
QUARTER GROWTHS
3/214/211/222/223/224/22
Revenuen/an/an/an/an/an/a
Gr.Profitn/an/an/an/an/an/a
Ebit
Asset
Debtn/an/an/a
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE 42.82 | sector: PE 0
PE RATIO: COMPANY / INDUSTRY
0x
Company: PE 42.82 | industry: PE 0
DISCOUNTED CASH FLOW VALUE
N/A
N/A
Expected Trading Range (DAY)

$ 10.01 - 10.03

( +/- 0.12%)
ATR Model: 14 days

Forecast: 01:40 - $10.35

Live Trading Signals (every 1 min)

SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $10.02 (-0.69% )
Volume 0.0215 mill
Avg. Vol. 0.0006 mill
% of Avg. Vol 3 702.75 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for Eucrates Biomedical Acquisition Corp.

Last 12 Months

Last 12 months chart data with high, low, open and close for Eucrates Biomedical Acquisition Corp.

RSI

Intraday RSI14 chart for Eucrates Biomedical Acquisition Corp.

Last 10 Buy & Sell Signals For EUCRU

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Profile picture for
            Eucrates Biomedical Acquisition Corp.

EUCRU

Eucrates Biomedical Acquisition Corp. does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It focuses to identify and acquire a business in the biomedical or healthcare-related industries in North America and Europe. The company was incorporated in 2020 and is based in New York, New York.

Last 10 Buy Signals

Date Signal @
OGUSDMar 29 - 08:105.93
CGOUSDMar 29 - 08:1171.85
XCADUSDMar 29 - 08:091.460
SFUNDUSDMar 29 - 08:09$4.55
STRKUSDMar 29 - 08:09$14.22
LPTUSDMar 29 - 08:10$18.98
PBTCUSDMar 29 - 08:085 553.51
FTMUSDMar 29 - 08:10$0.984
CBKUSDMar 29 - 08:091.088
APTUSDMar 29 - 08:0917.13

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.